P

Porton Pharma Solutions Ltd
SZSE:300363

Watchlist Manager
Porton Pharma Solutions Ltd
SZSE:300363
Watchlist
Price: 16.65 CNY 1.46% Market Closed
Market Cap: 9.1B CNY
Have any thoughts about
Porton Pharma Solutions Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Porton Pharma Solutions Ltd

Current Assets 3.1B
Cash & Short-Term Investments 1.5B
Receivables 702.1m
Other Current Assets 944.6m
Non-Current Assets 5.8B
Long-Term Investments 393.1m
PP&E 4.2B
Intangibles 565m
Other Non-Current Assets 577.6m
Current Liabilities 1.4B
Accounts Payable 617.5m
Accrued Liabilities 118.9m
Short-Term Debt 256.6m
Other Current Liabilities 429.2m
Non-Current Liabilities 2.1B
Long-Term Debt 1.7B
Other Non-Current Liabilities 444.3m

Balance Sheet
Porton Pharma Solutions Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
291
109
459
277
1 346
1 072
1 172
1 077
2 515
1 956
Cash
0
1
0
0
0
0
0
1 077
2 515
1 956
Cash Equivalents
291
109
458
277
1 346
1 072
1 172
0
0
0
Short-Term Investments
0
0
0
1
570
0
4
3
25
0
Total Receivables
299
298
335
302
408
390
452
1 192
1 613
736
Accounts Receivables
293
263
300
266
253
349
401
1 074
1 483
684
Other Receivables
6
35
35
36
156
41
51
118
130
51
Inventory
152
281
292
270
270
343
430
757
902
717
Other Current Assets
69
83
27
42
166
121
125
182
432
246
Total Current Assets
812
772
1 113
891
2 760
1 927
2 182
3 211
5 463
3 654
PP&E Net
951
1 334
1 450
1 520
1 240
1 308
1 552
2 435
3 485
4 212
PP&E Gross
951
1 334
1 450
1 520
1 240
1 308
1 552
2 435
3 485
4 212
Accumulated Depreciation
99
140
195
321
356
460
570
751
1 083
1 359
Intangible Assets
73
113
109
128
90
85
90
131
267
275
Goodwill
9
151
148
242
247
249
242
280
330
291
Long-Term Investments
0
1
38
46
18
350
369
382
377
392
Other Long-Term Assets
10
9
14
20
20
38
62
123
222
559
Other Assets
9
151
148
242
247
249
242
280
330
291
Total Assets
1 855
N/A
2 379
+28%
2 872
+21%
2 848
-1%
4 374
+54%
3 956
-10%
4 497
+14%
6 562
+46%
10 144
+55%
9 384
-7%
Liabilities
Accounts Payable
286
221
239
193
169
209
295
596
638
572
Accrued Liabilities
41
28
59
32
31
64
92
215
497
197
Short-Term Debt
389
437
786
450
720
207
362
904
1 453
244
Current Portion of Long-Term Debt
85
126
159
221
256
105
161
120
100
261
Other Current Liabilities
86
78
74
78
57
63
74
284
328
117
Total Current Liabilities
887
890
1 318
975
1 233
647
984
2 119
3 016
1 391
Long-Term Debt
93
310
184
422
255
242
107
231
520
1 692
Deferred Income Tax
0
0
0
0
0
0
3
8
71
91
Minority Interest
64
60
87
74
0
2
2
205
469
299
Other Liabilities
0
0
0
1
2
2
10
18
65
110
Total Liabilities
1 044
N/A
1 260
+21%
1 588
+26%
1 473
-7%
1 491
+1%
889
-40%
1 106
+24%
2 580
+133%
4 141
+60%
3 583
-13%
Equity
Common Stock
109
422
425
425
543
543
543
544
546
546
Retained Earnings
386
483
638
720
833
994
1 262
1 728
3 628
3 293
Additional Paid In Capital
325
225
263
261
1 587
1 589
1 635
1 799
1 958
2 067
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
0
0
Treasury Stock
0
0
32
18
75
67
44
62
133
135
Other Equity
9
11
10
11
6
8
4
27
4
29
Total Equity
811
N/A
1 120
+38%
1 284
+15%
1 376
+7%
2 883
+110%
3 067
+6%
3 391
+11%
3 982
+17%
6 003
+51%
5 801
-3%
Total Liabilities & Equity
1 855
N/A
2 379
+28%
2 872
+21%
2 848
-1%
4 374
+54%
3 956
-10%
4 497
+14%
6 562
+46%
10 144
+55%
9 384
-7%
Shares Outstanding
Common Shares Outstanding
409
422
422
423
535
534
534
538
538
538

See Also

Discover More